4
Changes in Ownership
Annexon, Inc. Filed Acc 0001567619-21-007133
EVP & Chief Scientific Officer sold 16,175 shares at an average $28.80 ($465,770)
- EVP & Chief Scientific Officer acquired 16,175 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Yednock Ted · EVP & Chief Scientific Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-25 | Exercise or conversion : show line 1 in the form | +15,000 | $1.41 | $21,144 | 15,000 | D |
| 2021-03-25 | Exercise or conversion : show line 2 in the form | +1,175 | $5.11 | $6,004 | 16,175 | D |
| 2021-03-25 | Sale : show line 3 in the form | −10,258 | $28.54 | $292,755 | 5,917 | D |
| 2021-03-25 | Sale : show line 4 in the form | −5,680 | $29.21 | $165,914 | 237 | D |
| 2021-03-25 | Sale : show line 5 in the form | −237 | $29.96 | $7,101 | 0 | D |
| Open-market sales · 16,175 sh · avg $28.80 · $465,770 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-25 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −15,000 | 40,615 | D |
| 2021-03-25 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −1,175 | 69,129 | D |
Loading xslF345X03/doc1.xml…